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Abstract
Background: Immunosenescence, i.e. the aging-associated decline of the capacity of the immune system, is
characterized by several distinct changes in the number and functions of the immune cells. In the case of B cells,
the total number of CD19+ B cells is lower in the blood of elderly individuals than in the younger ones. CD19+ B
cell population contains several subsets, which are commonly characterized by the presence of CD27 and IgD
molecules, i.e. naïve B cells (CD27- IgD+), IgM memory (CD27+ IgD+), switched memory (CD27+ IgD-) and late
memory (CD27- IgD-). This late memory, double negative, population represents cells which are nondividing, but
are still able to produce inflammatory mediators and in this way maybe contributing to the aging-associated
inflammation, inflammaging. Here we have focused on the role of these B cell subsets in elderly individuals,
nonagenarians, in the regulation of inflammation and inflammation-associated decline of bodily functions. As the
biological aging process demonstrates gender-specific characteristics, the analyses were performed separately in
males and female.
Results: A subcohort of The Vitality 90+ study (67 nonagenarians, 22/45 males/females and 40 young controls,
13/27 males/females) was used. Flow cytometric analysis indicated that the total percentage of the CD19+ cells was ca.
50% lower in the nonagenarians than in the controls in both genders. The proportions of these four B cell subsets
within the CD19+ populations were very similar in young and old individuals. Thus, it seems that the aging-associated
decline of the total CD19+ cells affects similarly all these B cell subsets. To analyze the role of these subsets in the
regulation of inflammation, the correlation with IL-6 levels was calculated. A significant correlation was observed only
with the percentage of CD27- IgD- cells and only in males. As inflammation is associated with aging-associated
functional performance and frailty, the correlations with the Barthel index and frailty score was analyzed. Again, only
the CD27- IgD- population demonstrated a strong male-specific correlation.
Conclusions: These data show that the CD27- IgD- B cell subset demonstrates a strong pro-inflammatory effect in
nonagenarians, which significantly associates with the decline of the bodily functions. However, this phenomenon is
only observed in males.
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Background
The impact of aging on the function of the immune sys-
tem is commonly called immunosenescence. Both the
changes at the level of individual cells of the immune
system as well as the clinical diseases associated with its
presence are relatively well characterized (for recent re-
views, see [1, 2]). The immune system contains several
functional entities such as innate/non-adaptive immune
response, inflammation, and adaptive (B and T cell me-
diated) immune response and all of these are clearly af-
fected by aging.
One distinct component of immunosenescence is the
increased rate of inflammation, often called inflamma-
ging (reviewed in [3]). It is a chronic, sterile, low grade
inflammation that is manifested by an increase of several
markers of inflammation in the blood of elderly individ-
uals. It is currently recognized as the main driving force
of the aging-associated phenotypic changes and a signifi-
cant risk factor for the aging-associated diseases
(reviewed in [4]). Although these adverse effects of
inflammaging are now better characterized, the factors
inducing inflammaging or modulating its activity are
still, at least partly, unknown. These factors could be
categorized as follows: i) infectious agents not eliminated
by the aging immune system ii) cellular debris released
from an ongoing degenerative disease (in some cases this
would indicate reverse causality, i.e. inflammation is a
consequence rather than cause of this disease process)
iii) environmental and life-style factors iv) aging-associ-
ated increase or activity of a given cell type having a
pro-inflammatory activity.
There are four relatively well-characterized CD19+ cell
subtypes in the human peripheral blood i.e. naïve (CD27-
IgD+), IgM memory (CD27+ IgD+), switched memory
(CD27+ IgD-) and late memory (CD27- IgD-) [5]. Although
there are obvious inter-individual differences and variation
in the analysis methods it seems that the total percentage
of CD19+ cells is decreased in aged individuals and conse-
quently, also the number of the cells in these subsets is
lower [5]. It is very likely that the activity of the CD27-
IgD- subset contributes to inflammaging as it has the char-
acteristics of the senescence-associated secretory phenotype
(SASP) (nondividing, metabolically active and secreting
proinflammatory cytokines) (reviewed in [6]). SASP pheno-
type in the cells of the immune system is probably a conse-
quence of the general cellular senescence, which is known
to be involved in the pathogenesis of many common dis-
eases (e.g. diabetes, hypertension, tumorigenesis) (reviewed
in [7]). In the case of immune/inflammatory diseases in-
creased SASP activity has been observed in several infec-
tions and autoimmune diseases (reviewed in [8]).
In this study, we analyzed the significance of the
CD27- IgD- B cells on the development of the serious
aging-associated condition, i.e. frailty.
Methods
Study population
The study population consisted of 67 nonagenarians (22
males, 45 females) and 40 young controls (age 19–29
years, 13 males, 27 females) who were participants in the
Vitality 90+ study, an ongoing population-based study
involving individuals aged 90 years or older and living in
the city of Tampere, Finland. The recruitment and
characterization of the participants in this cohort have
been characterized [9, 10]. The study protocol was ap-
proved by the ethics committee of the city of Tampere
(1592/403/1996) and the study was conducted according
to the principles expressed in the declaration of Helsinki.
Collection of the blood samples and purification of per-
ipheral blood mononuclear cells (PBMC) have recently
been published in detail [11].
Flow cytometry
After thawing, samples were washed with 1% fetal bo-
vine serum (FBS) in phosphate-buffered saline (PBS) and
incubated with Human BD Fc Block™ (BD, Franklin
Lakes, NJ, US) for 10 min at room temperature. Cells
were then surface stained with a mixture of the follow-
ing mouse anti-human antibodies (all eBioscience™ from
Thermo Fisher Scientific, Waltham, MA, US): FITC-IgD
(clone IA6–2), PE-CD43(clone eBio84-3C1), PerCP-
Cy5.5-CD19 (clone HIB19), PE-Cy7-CD27 (clone C323),
APC-eFluor780-CD3 (clone UCHT1), APC-eFluor-CD14
(clone 61D3), APC-eFluor780-CD56 (clone CMSSB) and
APC-CD20 (clone 2H7). After 20min at 4 °C, the cells
were washed twice with 1% FBS in PBS and samples were
analyzed with FACSCanto II (BD). Further analysis was
performed with FlowJo software (Ashland, OR, US). Gat-
ing was based on fluorescence minus one controls with
slight adjustments according to individual variation. Deb-
ris and clearly apoptotic cells were excluded by FSC/SSC
gating, but due to limitations in flow cytometer detector
availability, staining for viability and CD45 was not per-
formed. The PE-CD43 and APC-CD20 antibodies were in-
cluded in the original antibody mixture for purposes
outside the scope of this report.
Assessment of functional performance and frailty
Physical performance in everyday life was assessed using
the 10-item Barthel index [12]. It includes the activities
required for daily living (such as mobility, dressing, feed-
ing, toilet use, bowel and bladder control). Each task was
scored individually (0–10) and the total score of 100 in-
dicates maximum independence and the score 0 reflects
total dependence. The frailty index was calculated as de-
scribed in detail by Fried et al. [13]. The criteria included
1) mini-mental state examination (MMSE) score 2)
weight loss 3) self-reported fatigue 4) hand grip strength
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5) mobility. The sum of these criteria gives the final
index (min 0, max 5).
IL-6 quantification
The plasma interleukin 6 (IL-6) concentration was mea-
sured using the Pelikine human IL-6 ELISA kit (Sanguin,
Amsterdam, The Netherlands).
Statistical analysis
The differences in proportions of CD19+ cells, in pro-
portions of B cell subsets, and plasma IL-6 levels be-
tween nonagenarian group and young group were
analyzed using Mann-Whitney U test. Spearman’s Rank-
Order correlation was used to test the association of B
cell subsets with plasma IL-6 levels, Barthel index and
Frailty index. All statistical analyses were performed
using IBM SPSS Statistics version 25.
Results
As reported in previous studies, the percentage of
CD19+ B cells was clearly reduced in the elderly individ-
uals as compared to the young controls. In the flow-cy-
tometric analysis this was observed both by gating
directly the CD19+ cells and after first gating out the
CD3+, CD14+ and CD56+ cells. This reduction was
slightly stronger in females (p < 0.001, using both gating
strategies) than in males (p = 0.002 and p = 0.011 with
direct gating and with gating out the dump channel
(CD3, CD56 and CD14), respectively) (Fig. 1.).
The proportions of the CD27- IgD-, CD27- IgD+,
CD27+ IgD+ and CD27+ IgD- subpopulations are
shown in Fig. 2. It shows that the naïve B cells (CD27-
IgD+) form the majority in both young and old individ-
uals and in both genders.
In the case of the three memory cell populations the gen-
eral pattern of the proportions (Fig. 2.) indicates that age and
gender associated differences are minor. However, in females
the higher proportion of CD27-IgD- cells (p = 0.009) and
lower proportions of CD27+ IgD+ cells (p = 0.002) and
CD27- IgD+ cells (p = 0.022) in nonagenarians as compared
to controls were statistically significant. There was no signifi-
cant aging associated difference in the CD27+ IgD- subpopu-
lation. In the case of males, all age associated differences in
the CD19+ subpopulation proportions were non-significant
(p = 0.113, p = 0.159, p = 0.057 and p = 0.139 for CD27+
IgD-, CD27+ IgD+, CD27 -IgD+ and CD27- IgD-,
respectively).
Taken together, the data this far shows that aging does
not have a profound effect on the relative proportions of
these B cell subsets; as the total number of B cells is
clearly reduced (ca. 50%, see Fig. 1.) it can be concluded
that also the total cell number of the four subsets are re-
duced in the aged individuals. To confirm that age asso-
ciated reduction in CD19+ cells affects all CD19+
subpopulations, cell numbers, from which the subpopu-
lation proportions were calculated, were also examined.
The distributions of the cell numbers of the CD19+ sub-
populations are shown in Fig. 1 (panels C and D). These
distributions are clearly similar in shape over gender and
age. Only notable difference seems to be the overall
magnitude of the cell numbers over the age, that is ex-
plained by the difference in the number of CD19+ cells
between nonagenarians and young individuals. This con-
cludes that the age associated decrease in the CD19+
cells affects all the studied CD19+ subpopulations.
To examine the functional role of these B cell subsets,
their associations with the serum levels of IL-6, i.e. the
prototype proinflammatory cytokine, were analyzed. Fig-
ure 3 demonstrates that IL-6 levels were increased in the
elderly individuals, both in males (p = 0.007) and females
(p = 0.010). The data shown in Table 1 demonstrate that
these levels correlated only with the proportion of the
CD27- IgD- subset but only in males; thus, in males, the
higher proportion of the cells were CD27- IgD-, the
higher the plasma IL-6 level was.
Aging is associated with a decline of the physical cap-
acity in everyday life as well as increased vulnerability to
endogenous and exogenous stressors. These changes are
commonly quantitated using the Barthel and frailty indi-
ces, respectively. As inflammation is known to be associ-
ated with these parameters, we next analyzed the
correlations of the B cell subsets with these indices.
Table 2 shows that both of these indices correlate sig-
nificantly only with the percentage of the CD27- IgD-
population but only in males. Thus, this cell population
seems to be involved in the mechanisms leading to the
decline of functional capacity (negative correlation with
the Barthel index) and increasing frailty.
Gender did not have a significant effect on these indi-
ces (Barthel, mean 83 in females and 79 in males, frailty
mean 2.1 in males and 2.5 in females). The original
frailty index (min 0, max 5) was also modified to a 3 step
index (0–1 = non-frail, 2–3 = pre-frail, 4–5 = frail). The
number of nonagenarian male individuals in each frailty
group were 3, 8 and 11 for the non-frail, pre-frail and
frail, respectively, and the number of nonagenarian fe-
male individuals in each frailty group were 2, 20 and 17
for the non-frail, pre-frail and frail, respectively. The
data shown in Fig. 4 shows that the percentage of the
CD27- IgD- is ca. 3 times higher in the frail males than
in the non-frails.
Discussion
The findings reported here are in line with the previous
data demonstrating that the CD27- IgD- B cell memory
subset has a pro-inflammatory character. However, two
novel aspects were observed. Firstly, its effect was so
strong that there was a clear correlation with its
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increased proportion and the aging-associated decline of
the physical capacity of the elderly individuals. Secondly,
its effect was restricted to males.
As stated above, the CD19+ CD27- IgD- cells have a
clear SASP phenotype, and are extensively characterized
[5]. They are able to produce pro-inflammatory cyto-
kines (tumor necrosis factor (TNF), IL-6, interleukin 8
(IL-8)) and contain typical inflammatory micro-RNAs.
Obviously, they are already in a pre-activated stage. They
also contribute to a functionally important parameter of
immunosenescence, i.e. reducing the efficacy of vaccina-
tions (at least in the case of influenzavirus) [14]. The
data shown here that this cell type has a deleterious ef-
fect on the physiological reserves of the elderly individ-
uals, as quantitated with the frailty index. It is unlikely,
that a cell type with such a low frequency (less than 5%
of the total PBMC number) would alone be responsible
for such an effect. Thus, it is feasible that increase or ac-
tivity of additional cell types with SASP phenotype
would contribute to the observed effect. In fact, we ad-
dressed this question by analyzing the role of CD8+
CD28- T lymphocytes, i.e. a well-defined cell type with the
SASP phenotype [15], in the same way as described here.
However, the frequency of these cells did not correlate with
any of the parameters used in this study (data not shown).
It has been shown that frailty is associated with several
markers of inflammation, [16]. As frailty is a complex
phenotype affecting many organs and tissues and prob-
ably also via various molecular pathways, it is obvious
that it is not induced by a single molecule. In this study,
Fig. 1 CD19+ B cell proportions and gating strategy. Comparison of the median CD19+ B cell proportions in the PBMCs of nonagenarian individuals
and young individuals was analyzed with gating directly to CD19 from non-debris gate (blue) and with first gating out the CD3+, CD14+ and CD56+
(red). Error bars represent 95% confidence interval. a Median B cell proportions in nonagenarian males and young males. Significance for the age
difference was p = 0.02 for the non-debris CD19+ cells and p = 0.011 for the dump-negative CD19+ cells. b Median B cell proportions in nonagenarian
females and young females. Significance for the age difference was p < 0.001 for the non-debris CD19+ cells and p < 0.001 for the dump-negative
CD19 + cells. c Gating strategy for CD19+ B cells. The percentage of CD19+ cells was determined after exclusion of debris (non-debris gate) and cell
doublets (singlets gate), or after additionally gating out cells that express T cell, NK cell and monocyte lineage markers CD3, CD56 and CD14,
respectively (“dump channel”, dump negative gate)
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we used IL-6 levels to quantitate the inflammation. IL-6
levels were associated much more weakly with the frailty
index than the percentage of CD27- IgD- cells (data not
shown), underlining the importance of yet uncharacter-
ized factors in the pathogenesis of frailty.
The pro-inflammatory effect of the CD27- IgD- B cells
was restricted to males. This is in line with our previous
data [17]. In that study, we examined the correlation of
IL-6 levels with transcriptomic and epigenetic changes
in PBMCs of nonagenarians. In males, there were several
Fig. 2 Genderwise comparison of the distributions of the CD19+ B cell subpopulation proportions and the CD19+ subpopulation gating strategy. a Median
B cell subpopulation proportions in nonagenarian males and young males. P-values of the significances for the aging-associated differences were 0.113, 0.159,
0.057 and 0.139 for CD27+ IgD-, CD27+ IgD+, CD27 -IgD+ and CD27- IgD-, respectively. b Median B cell subpopulation proportions in nonagenarian females
and young females. P-values of the significances for the aging-associated differences were 0.083, 0.002, 0.022 and 0.009 for CD27+ IgD-, CD27+ IgD+, CD27
-IgD+ and CD27- IgD-, respectively. Error bars represent 95% confidence interval. c Median B cell subpopulation cell numbers in nonagenarian males and
young males. d Median B cell subpopulation cell numbers in nonagenarian females and young females. e Gating strategy of CD19+ B cell subpopulations.
Representative samples from a young adult and a nonagenarian donor are shown. Numbers indicate population frequencies
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transcripts correlating with IL-6 levels while in females
there were none. These transcripts were involved in pro-
cesses that were linked to inflammatory pathways. Thus,
it seems likely, that the effect of the IL-6 component of
inflammaging is gender-dependent. Obviously, this does
not mean that all the effects of the CD27- IgD- cells
would be restricted to males.
In this study, we used two indices, Barthel and frailty,
to quantitate the aging-associated biological and func-
tional deficiencies. Although the measured parameters
or the questions asked in the calculation of these indices
are different, they correlated significantly. This is not un-
expected, as it is likely that decline of the biological cap-
acity. i.e. frailty, probably leads to the functional
deficiencies quantitated with the Barthel index. Although
inflammaging associates with several disease states and
pathogenic mechanisms (see above), it is probable that it
is not functionally uniform entity, i.e. different forms of
inflammaging have different targets. Individual analysis
of the different assessment steps in the calculation of the
frailty index might be informative in this respect. We
observed that the CD27- IgD- proportion correlated very
significantly with the muscle strength (the handgrip
test), but only weakly with the cognitive status (MMSE
test, data not shown). Thus, it is possible that the CD27-
IgD- population associated inflammation affects prefer-
entially the physical capacity (muscles, circulation).
The elderly individuals used in this study were nonage-
narians, i.e. the biological aging process had progressed very
far. It would be of interest to analyze the role of this CD27-
IgD- cell type associated phenomena on the earlier stages
of physical aging, e.g. at the age of 60–80 years, preferably
in a follow-up setting. Unfortunately, such samples are not
available in the Vitality 90+ cohort. A positive influence ob-
served in these “younger” ones would maybe indicate that
the effect of these CD27- IgD- cells is more general and
would influence the pace of the decline of the physical
functions. The reverse results, such that the findings would
be restricted to nonagenarians, could be explained with dif-
ferential inflammatory mediator profiles; the composition
of the factors in the pool of the inflammatory mediators
could be different between these age groups. However, in
this study we used IL-6 as the marker of inflammation, i.e.
the cytokine showing the male-restricted activity [17], while
IL-1 levels, although increased in the nonagenarians, did
not associate with the proportion of the CD27- IgD- cells
(data not shown). Moreover, the central role of IL-6
in the present observations is further emphasized by
its role as a biomarker, even an inducer of sarcopenia,
(reviewed in [18]).
As for the male-specificity of the observed associa-
tions, it was quite surprising that the observed correla-
tions between the proportion of CD27- IgD- cells and
frailty and Barthel indexes were restricted to males. At
Fig. 3 Genderwise comparison of median plasma Interleukin-6 concentrations in nonagenarian individuals and young individuals. IL-6 levels were
significantly increased in nonagenarian males as compared to young males (p = 0.007), and in nonagenarian females as compared to young
females (p = 0.010). Error bars represent 95% confidence interval
Table 1 Spearman correlation of the plasma IL-6 levels (pg/ml)
with the proportions of the B cell subsets in nonagenarians (22
males, 39 females)
B cell subset gender correlation coefficient p-value
CD27- IgD- male 0.666 < 0.001
female 0.183 0.265
CD27- IgD+ male −0.253 0.256
female −0.150 0.362
CD27+ IgD+ male −0.217 0.331
female 0.004 0.982
CD27+ IgD- male −0.300 0.175
female 0.015 0.926
Correlation coefficient and significance of statistically significant associations
are indicated in boldface
Nevalainen et al. Immunity & Ageing           (2019) 16:19 Page 6 of 9
present, the molecular/cellular background of this
phenomenon is open and can only be speculated. Firstly,
it is obvious that the number of the CD27- IgD- cells as
such is not decisive, i.e. the proportion of these cells is
even somewhat higher in females than in males (Fig. 2).
Secondly, the production and effect of the proinflamma-
tory cytokines could have a role. In this study, we used
IL-6 as the indicator. Its serum levels were ca. two times
higher in nonagenarian males than in females (Fig. 3),
and correlated significantly with the proportion of the
CD27- IgD- cells but only in males. Moreover, IL-6
levels demonstrated a weak correlation with the frailty
index (p < 0.05 in males). We have previously shown
that in male PBMCs IL-6 is a more potent activator than
in female cells [17]. Thus, taken together, it is likely that
both the IL-6 producer cell type, as well as the
Table 2 Spearman correlation of the Barthel and frailty indices with the proportions of the B cell subsets in nonagenarians
B cell subset gender r (Barthel index) p-value (Barthel index) r (Frailty index) p-value (Frailty index)
CD27- IgD- male −0.601 0.003 0.616 0.002
female −0.274 0.091 0.157 0.34
CD27- IgD+ male 0.180 0.423 −0.387 0.076
female 0.332 0.039 −0.181 0.27
CD27+ IgD+ male 0.339 0.123 −0.148 0.512
female −0.173 0.293 −0.113 0.492
CD27+ IgD- male 0.358 0.102 −0.036 0.874
female −0.256 0.116 −0.003 0.983
Correlation coefficient and significance of statistically significant associations are indicated in boldface
Fig. 4 Distribution of CD19+ B cell subpopulations in nonagenarian individuals categorized with frailty index. a Nonagenarian males. b
Nonagenarian females. Error bars represent 95% confidence interval
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responsiveness to it, might be involved in the observed
gender difference. Thirdly, it has been shown that the
frailty index is gender-dependent to a certain extent, i.e.
it is somewhat higher in females than in males of the
same age [19] and the clinical consequences of its in-
crease are different in males and females [20]. It is pos-
sible that these differences are due to the differences in
the inflammatory response, or the causality could be re-
verse, i.e. the pathogenic changes associated with the ad-
vancing frailty would activate inflammation in a gender-
specific manner.
As CD27- IgD- B cells seem to be very potent activa-
tors of inflammaging, even associating with adverse
aging-associated effects, it is tempting to speculate that
they could be a target for anti-aging therapies. In fact,
Moura et al. [21] have recently shown that the increased
number of CD27- IgD- cells in rheumatoid arthritis pa-
tients can be reduced back to normal levels with anti-
TNF or anti-IL6 receptor antibodies.
Conclusion
We observed that CD27- IgD- B cell subset demon-
strates a strong pro-inflammatory effect in nonagenarian
males, which significantly associates with the decline of
the bodily functions. As CD27- IgD- B cells seem to
contribute to inflammaging and its adverse effects, they
might be an attractive target for anti-aging therapies.
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